Registration is open! You have another 56 days to submit your application.

Registration is open! You have another 56 days to submit your application.

APPLY

Hydra Therapeutics

Health Sciences and Wellness

Hydra Therapeutics is a veterinary biotechnology company developing regenerative treatments for animals with musculoskeletal and renal conditions, such as osteoarthritis and chronic joint pain in dogs, horses and cats.

The company's core technology, HydraEXO, uses extracellular vesicles – natural nanoparticles released by stem cells – to reduce inflammation and support tissue repair, without the higher cost and complexity of using live stem cells directly.

Unlike most current treatments, which manage pain rather than treat its cause, Hydra Therapeutics’ treatments aim to actively repair damaged tissue, giving veterinarians and pet owners a longer-lasting alternative to repeated injections or surgery.

The company is also adapting the technology for military and government working dogs, whose physical demands accelerate joint wear and shorten service life. In the long term, this veterinary pathway is designed to serve as a lower-risk bridge toward the same regenerative therapies in human medicine.